A Phase 3 Open Label Multicenter Study of the Safety & Efficacy of Brincidofovir CMX001 in the Treatment of Early versus Late Adenovirus Infection. Chimerix Study CMX001-304
Clinical Trial Grant
Administered By
Pediatrics, Transplant and Cellular Therapy
Awarded By
Chimerix, Inc.
Start Date
April 18, 2014
End Date
January 31, 2017
Administered By
Pediatrics, Transplant and Cellular Therapy
Awarded By
Chimerix, Inc.
Start Date
April 18, 2014
End Date
January 31, 2017